Cognizin Citicoline Dosing in a Healthy Adolescent Male Population

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Neurocognitive Improvement

In brief

To determine the functional effects of Citicoline, a natural supplement, when administered for a duration of four weeks (28 days) to non-psychiatric adolescent male participants. The investigators hypothesize that citicoline will provide cognitive benefits to this population after 28 days of supplementation.

Key facts

Study ID

NCT01582113

Run by

Deborah Yurgelun-Todd

People needed

84

Starts

2012-06-01

Expected to finish

2017-05-24

Last updated by the study team

2019-02-18

Who can join

Age: 13 and older, up to 18. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male
• Age 13-18 years old
• No history of co-morbid psychiatric disorder, current Axis I or II diagnosis or previous pharmacotherapeutic trial

You may not qualify if…

• Head injury with LOC > 5 minutes
• Use of any psychotropic medication

Where it is running

• The Brain Institute, University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.